Javascript must be enabled to continue!
Household Coverage of Ivermectin Distribution in Birnin Kudu Local Government Area of Jigawa State, Nigeria
View through CrossRef
Purpose:
To assess community-directed treatment coverage with Ivermectin (CDTI) in Onchocerciasis-endemic communities in Birnin Kudu local government area (LGA) Jigawa state.
Subjects and Methods:
This was a community-based multistaged cross-sectional survey based on probability proportional to size. The study involved the administration of a questionnaire on 2021 respondents from 207 households. Also, 30 Community Leaders and Community Directed Distributors (CDDs) were purposively selected for interview from the communities visited.
Results:
Overall, 2021 respondents from the 2031 sampled population took part in the study giving a response rate of 99.6%. Slightly above half, 1130 (55.9%) were males. The geographic and therapeutic coverage of mass drug administration of Ivermectin achieved in the LGA was 100% and 79.9%, respectively. The key factors affecting coverage includes the unavailability of drugs (48.8%), absenteeism of some of the household members (31%), and inadequate incentives to the CDDs by the government and poor record keeping by the CDDs.
Conclusion:
This study found that the minimum geographic and therapeutic coverage of Ivermectin distribution was achieved by CDD as recommended by the World Health Organization for the control of onchocerciasis. For this to be sustained and to achieve elimination, there must be an adequate supply of ivermectin, training of CDDs, retraining of CDDs, adequate supervision in record keeping, and health education to the community.
Title: Household Coverage of Ivermectin Distribution in Birnin Kudu Local Government Area of Jigawa State, Nigeria
Description:
Purpose:
To assess community-directed treatment coverage with Ivermectin (CDTI) in Onchocerciasis-endemic communities in Birnin Kudu local government area (LGA) Jigawa state.
Subjects and Methods:
This was a community-based multistaged cross-sectional survey based on probability proportional to size.
The study involved the administration of a questionnaire on 2021 respondents from 207 households.
Also, 30 Community Leaders and Community Directed Distributors (CDDs) were purposively selected for interview from the communities visited.
Results:
Overall, 2021 respondents from the 2031 sampled population took part in the study giving a response rate of 99.
6%.
Slightly above half, 1130 (55.
9%) were males.
The geographic and therapeutic coverage of mass drug administration of Ivermectin achieved in the LGA was 100% and 79.
9%, respectively.
The key factors affecting coverage includes the unavailability of drugs (48.
8%), absenteeism of some of the household members (31%), and inadequate incentives to the CDDs by the government and poor record keeping by the CDDs.
Conclusion:
This study found that the minimum geographic and therapeutic coverage of Ivermectin distribution was achieved by CDD as recommended by the World Health Organization for the control of onchocerciasis.
For this to be sustained and to achieve elimination, there must be an adequate supply of ivermectin, training of CDDs, retraining of CDDs, adequate supervision in record keeping, and health education to the community.
Related Results
Impact of ivermectin components on Anopheles dirus and Anopheles minimus mosquito survival
Impact of ivermectin components on Anopheles dirus and Anopheles minimus mosquito survival
Abstract
Background
Ivermectin mass drug administration to humans or livestock is a potential vector control tool for malaria elimination. Racemic i...
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Abstract
Purpose
In areas of Africa where ivermectin is widely used as prophylaxis against neglected tropical diseases, COVID-19 morbidity and mortality are markedly lower...
AN EXAMINATION OF THE FACTORS RESPONSIBLE FOR ONLINE ADVANCE FEE FRAUD VICTIMIZATION AMONG YOUTHS IN BIRNIN KUDU LOCAL GOVERNMENT AREA, JIGAWA STATE, NIGERIA
AN EXAMINATION OF THE FACTORS RESPONSIBLE FOR ONLINE ADVANCE FEE FRAUD VICTIMIZATION AMONG YOUTHS IN BIRNIN KUDU LOCAL GOVERNMENT AREA, JIGAWA STATE, NIGERIA
The study examines the factors responsible for online advance fee fraud victimization among
youths in Birnin Kudu Local Government Area of Jigawa State. The specific objectives set...
A comparative study on the efficacy of four anthelmintics on some important reindeer parasites
A comparative study on the efficacy of four anthelmintics on some important reindeer parasites
<p>Four anthelmintic preparations were tested against some of the most important parasites of reindeer, i.e. warble fly (Oedemagena tarandi), nostril fly (Cephenemyia trompe)...
Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds
Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds
Abstract
Background
Ivermectin is lethal to Anopheles mosquitoes and a novel approach to malaria transmission control. Ivermectin could be co-adm...
Ivermectin dan Covid-19: Sebuah Tinjauan Literatur
Ivermectin dan Covid-19: Sebuah Tinjauan Literatur
Coronavirus disease (COVID-19) is an infectious disease that has been declared a pandemic by WHO and has become a case of a health emergency in the world. This disease is caused by...
WITHDRAWN: Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
WITHDRAWN: Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
Abstract
Background: Up-to-date, there is no recognized effective treatment or vaccine for the treatment of COVID-19 that emphasize urgency around distinctive effec...
Reviewing Ivermectin’s Efficacy in Treating COVID-19 Infection
Reviewing Ivermectin’s Efficacy in Treating COVID-19 Infection
Background:
The use of antiviral therapies in addressing COVID-19 infection has been
subject to varying approaches across different jurisdictions during the initial two years of th...

